Download PDF
Semin Thromb Hemost 2018; 44(07): 656-661
DOI: 10.1055/s-0038-1639501
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Anxiety-Related Bleeding and Thrombosis

Silvia Hoirisch-Clapauch
1   Hematology Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
› Author Affiliations
Further Information

Publication History

Publication Date:
03 May 2018 (online)

    Permissions and Reprints

Abstract

Anxiety, a normal response to stressful situations, is characterized by increased levels of factor VIII, fibrinogen, and von Willebrand factor, and by enhanced platelet aggregability. One would expect acute anxiety to be a prothrombotic state, but since acute mental stress induces tissue plasminogen activator (tPA) release from endothelial and chromaffin cells, fibrinolysis counteracts procoagulant stimuli. It could be said that procoagulant changes accompanying the fight-or-flight response reduce the risk of bleeding in case of potential injuries, while activation of fibrinolysis counteracts activation of hemostasis to prevent intravascular thrombus formation before injuries occur. Acutely anxious patients are prone to bleeding or thrombosis when the balance between hypercoagulation and hyperfibrinolysis is disturbed. Acute anxiety not only increases the risk of bleeding in hemophilia or von Willebrand disease, but many reports have shown that anxiolytic interventions such as hypnosis are effective in controlling bleeding in hemostatic disorders. The pathogenesis of cardiovascular and thrombotic diseases in highly anxious patients is multifactorial. An important element is α-adrenergic vasoconstriction, which increases viscosity due to leakage of intravascular fluid into the interstitium, and also causes hypertension, favoring plaque rupture. Paradoxical as it may seem, over secretion of tPA may increase cardiovascular risk. This is because tPA degrades the extracellular matrix, causing vascular stiffness that increases cardiac workload, and thus oxygen requirements. Anxious patients with conditions associated with increased plasminogen activator inhibitor-1 levels, such as depression or postprandial hyperinsulinemia, are at high risk of thrombosis. Postprandial hyperinsulinemia may result from consumption of high-carbohydrate foods, considered anxiolytic, combined with a sedentary life, which is common among anxious individuals. Preliminary evidence suggests that high anxiety combined with either depression or a lifestyle that results in hyperinsulinemia has an important role in the pathogenesis of thrombotic events currently classified as unprovoked.

Keywords

anxiety - bleeding - depression - diet - sedentary - thromboembolism
 

  • References

  • 1 von Känel R. Acute mental stress and hemostasis: when physiology becomes vascular harm. Thromb Res 2015; 135: S52-S55
    CrossrefPubMedGoogle Scholar
  • 2 Larsson PT, Hjemdahl P, Olsson G, Egberg N, Hornstra G. Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin Sci (Lond) 1989; 76 (04) 369-376
    CrossrefPubMedGoogle Scholar
  • 3 Bai H, Nangia S, Parmer RJ. The plasminogen activation system and the regulation of catecholaminergic function. J Biomed Biotechnol 2012; 2012: 721657
    PubMedGoogle Scholar
  • 4 Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJJ. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32 (01) 117-122
    CrossrefPubMedGoogle Scholar
  • 5 von Känel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 2001; 63 (04) 531-544
    CrossrefPubMedGoogle Scholar
  • 6 Lee TW, Tsang VW, Birch NP. Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system. Front Cell Neurosci 2015; 9: 396
    PubMedGoogle Scholar
  • 7 McEwen BS, Morrison JH. The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 2013; 79 (01) 16-29
    CrossrefPubMedGoogle Scholar
  • 8 Levenstein S, Rosenstock S, Jacobsen RK, Jorgensen T. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastroenterol Hepatol 2015; 13 (03) 498-506.e1
    CrossrefPubMedGoogle Scholar
  • 9 Seidel DU, Jacob L, Kostev K, Sesterhenn AM. Risk factors for epistaxis in patients followed in general practices in Germany. Rhinology 2017; 55 (04) 312-318
    PubMedGoogle Scholar
  • 10 Fung EH, Lazar BS. Hypnosis as an adjunct in the treatment of von Willebrand's disease. Int J Clin Exp Hypn 1983; 31 (04) 256-265
    CrossrefPubMedGoogle Scholar
  • 11 Perrin JM, MacLean Jr WE, Janco RL, Gortmaker SL. Stress and incidence of bleeding in children and adolescents with hemophilia. J Pediatr 1996; 128 (01) 82-88
    CrossrefPubMedGoogle Scholar
  • 12 Gilliard P. Treize années à la cour de Russie, Le tragique destin de Nicolas II et de sa famille. Paris: Editions Payot & Rivages; 1921: 53
    Google Scholar
  • 13 LaBaw W. The use of hypnosis with hemophilia. Psychiatr Med 1992; 10 (04) 89-98
    PubMedGoogle Scholar
  • 14 Swirsky-Sacchetti T, Margolis CG. The effects of a comprehensive self-hypnosis training program on the use of factor VIII in severe hemophilia. Int J Clin Exp Hypn 1986; 34 (02) 71-83
    CrossrefPubMedGoogle Scholar
  • 15 Batelaan NM, Seldenrijk A, Bot M, van Balkom AJ, Penninx BW. Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. Br J Psychiatry 2016; 208 (03) 223-231
    CrossrefPubMedGoogle Scholar
  • 16 Schreijer AJ, Cannegieter SC, Doggen CJ, Rosendaal FR. The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol 2009; 144 (03) 425-429
    CrossrefPubMedGoogle Scholar
  • 17 Meltzer ME, Lisman T, de Groot PG. , et al. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood 2010; 116 (01) 113-121
    CrossrefPubMedGoogle Scholar
  • 18 Tofler GH, Massaro J, O'Donnell CJ. , et al. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study. Thromb Res 2016; 140: 30-35
    CrossrefPubMedGoogle Scholar
  • 19 Lowe G, Rumley A. The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?. Thromb Haemost 2014; 112 (05) 860-867
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Thrall G, Lane D, Carroll D, Lip GY. A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007; 120 (06) 819-847
    CrossrefPubMedGoogle Scholar
  • 21 O'Rourke J, Jiang X, Hao Z, Cone RE, Hand AR. Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature. J Neurosci Res 2005; 79 (06) 727-733
    CrossrefPubMedGoogle Scholar
  • 22 Leggio L, Addolorato G, Cippitelli A, Jerlhag E, Kampov-Polevoy AB, Swift RM. Role of feeding-related pathways in alcohol dependence: a focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res 2011; 35 (02) 194-202
    CrossrefPubMedGoogle Scholar
  • 23 Jag UR, Zavadil J, Stanley FM. Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1. Mol Endocrinol 2009; 23 (10) 1587-1602
    CrossrefPubMedGoogle Scholar
  • 24 Hiles SA, Lamers F, Milaneschi Y, Penninx BWJH. Sit, step, sweat: longitudinal associations between physical activity patterns, anxiety and depression. Psychol Med 2017; 47 (08) 1466-1477
    CrossrefPubMedGoogle Scholar
  • 25 Hou B, Eren M, Painter CA. , et al. Tumor necrosis factor α activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kB site. J Biol Chem 2004; 279 (18) 18127-18136
    CrossrefPubMedGoogle Scholar
  • 26 Hotamisligil GS. Foundations of immunometabolism and implications for metabolic health and disease. Immunity 2017; 47 (03) 406-420
    CrossrefPubMedGoogle Scholar
  • 27 Gold PW, Machado-Vieira R, Pavlatou MG. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. Neural Plast 2015; 2015: 581976
    PubMedGoogle Scholar
  • 28 Lahlou-Laforet K, Alhenc-Gelas M, Pornin M. , et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 2006; 97 (09) 1287-1291
    CrossrefPubMedGoogle Scholar
  • 29 Jiang H, Li X, Chen S. , et al. Plasminogen activator inhibitor-1 in depression: Results from animal and clinical studies. Sci Rep 2016; 6: 30464
    CrossrefPubMedGoogle Scholar
  • 30 Yoshida T, Ishikawa M, Niitsu T. , et al. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One 2012; 7 (08) e42676
    CrossrefPubMedGoogle Scholar
  • 31 Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012; 64 (02) 238-258
    CrossrefPubMedGoogle Scholar
  • 32 Joëls M, Karst H, Krugers HJ, Lucassen PJ. Chronic stress: implications for neuronal morphology, function and neurogenesis. Front Neuroendocrinol 2007; 28 (2–3): 72-96
    CrossrefPubMedGoogle Scholar
  • 33 Liu W, Ge T, Leng Y. , et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast 2017; 2017: 6871089
    PubMedGoogle Scholar
  • 34 Wurtman JJ, Wurtman RJ. Depression can beget obesity can beget depression. J Clin Psychiatry 2015; 76 (12) e1619-e1621
    CrossrefPubMedGoogle Scholar
  • 35 Dowlati Y, Herrmann N, Swardfager W. , et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67 (05) 446-457
    CrossrefPubMedGoogle Scholar
  • 36 Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 2013; 18 (06) 692-699
    PubMedGoogle Scholar
  • 37 Kunugi H, Hori H, Ogawa S. Biochemical markers subtyping major depressive disorder. Psychiatry Clin Neurosci 2015; 69 (10) 597-608
    CrossrefPubMedGoogle Scholar
  • 38 Uddén J, Eriksson P, Hoffstedt J. Glucocorticoid-regulated adipose tissue secretion of PAI-1, but not IL-6, TNF alpha or leptin in vivo. Horm Metab Res 2002; 34 (11–12): 698-702
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Gan Y, Gong Y, Tong X. , et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371
    CrossrefPubMedGoogle Scholar
  • 40 von Känel R, Margani A, Stauber S. , et al. Depressive symptoms as a novel risk factor for recurrent venous thromboembolism: a longitudinal observational study in patients referred for thrombophilia investigation. PLoS One 2015; 10 (05) e0125858
    CrossrefPubMedGoogle Scholar
  • 41 Lee CWS, Liao CH, Lin CL, Liang JA, Sung FC, Kao CH. Depression and risk of venous thromboembolism: a population-based retrospective cohort study. Psychosom Med 2015; 77 (05) 591-598
    CrossrefPubMedGoogle Scholar
  • 42 Geiser F, Conrad R, Imbierowicz K. , et al. Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants. Psychiatry Clin Neurosci 2011; 65 (05) 518-525
    CrossrefPubMedGoogle Scholar
  • 43 Geiser F, Gessler K, Conrad R, Imbierowicz K, Albus C, Harbrecht U. Can activation of coagulation and impairment of fibrinolysis in patients with anxiety and depression be reversed after improvement of psychiatric symptoms? Results of a pilot study. J Nerv Ment Dis 2012; 200 (08) 721-723
    CrossrefPubMedGoogle Scholar
  • 44 Zhong W, Kremers HM, Yawn BP. , et al. Time trends of antidepressant drug prescriptions in men versus women in a geographically defined US population. Arch Women Ment Health 2014; 17 (06) 485-492
    CrossrefPubMedGoogle Scholar
  • 45 Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S. Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001; 23 (04) 262-267
    CrossrefPubMedGoogle Scholar
  • 46 Rice SM, Aucote HM, Parker AG, Alvarez-Jimenez M, Filia KM, Amminger GP. Men's perceived barriers to help seeking for depression: longitudinal findings relative to symptom onset and duration. J Health Psychol 2017; 22 (05) 529-536
    CrossrefPubMedGoogle Scholar
  • 47 Iodice S, Gandini S, Löhr M, Lowenfels AB, Maisonneuve P. Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost 2008; 6 (05) 781-788
    CrossrefPubMedGoogle Scholar
  • 48 Jia Y, Li F, Liu YF, Zhao JP, Leng MM, Chen L. Depression and cancer risk: a systematic review and meta-analysis. Public Health 2017; 149: 138-148
    CrossrefPubMedGoogle Scholar
  • 49 Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5 (10) 617-625
    CrossrefPubMedGoogle Scholar
  • 50 Douketis J, Tosetto A, Marcucci M. , et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 342: d813
    CrossrefPubMedGoogle Scholar
  • 51 Moreno AIF, Navarro MJG, Sánchez JO. , et al. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES). Eur J Intern Med 2016; 29: 59-64
    CrossrefPubMedGoogle Scholar
  • 52 Ryu TY, Park J, Scherer PE. Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J 2014; 38 (05) 330-336
    CrossrefPubMedGoogle Scholar
  • 53 Shikata K, Ninomiya T, Kiyohara Y. Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 2013; 104 (01) 9-14
    CrossrefPubMedGoogle Scholar